Suchergebnisse - "Mortezaee, Keywan"

PubPharm (27)

1

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

enthalten in: Clinical and experimental medicine | 2024

von Mortezaee, K.

2

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

enthalten in: Clinical and experimental medicine | 2024

von Mortezaee, K.

3

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy : A focus on anti PD-1/PD-L1 antibodies

enthalten in: Life sciences | 2024

von Najafi, S. | Mortezaee, K.

4

Extracellular vesicle-based drug delivery in cancer immunotherapy

enthalten in: Drug delivery and translational research | 2023

von Najafi, S. | Majidpoor, J. | Mortezaee, K.

5

Dual anti-PD-(L)1/TGF-β inhibitors in cancer immunotherapy - Updated

enthalten in: International immunopharmacology | 2023

von Karami, Z. | Mortezaee, K. | Majidpoor, J.

6

The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4

enthalten in: Pathology, research and practice | 2023

von Parvini, S. | Majidpoor, J. | Mortezaee, K.

7

Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K. | Majidpoor, J.

8

B7-H3 immunoregulatory roles in cancer

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K.

9

Reinstating immunogenicity using bispecific anti-checkpoint/agent inhibitors

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K. | Majidpoor, J.

10

The impact of hypoxia on tumor-mediated bypassing anti-PD-(L)1 therapy

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K. | Majidpoor, J. | Kharazinejad, E.